PACS: financial statements from SEC — TradeAlmanac

PACS

PACS Group, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	1.42bn	1.34bn	1.31bn	1.28bn	1.03bn	936m
Cost of revenue	1.07bn	1.05bn	1.02bn	1.02bn	850m	762m
Selling, general and administrative	112m	103m	100m	99m	71m	137m
Operating expenses	1.30bn	1.26bn	1.23bn	1.23bn	1.00bn	973m
Operating income	120m	86m	80m	48m	23m	−37m
Pre-tax income	114m	76m	79m	43m	34m	−51m
Income tax	33m	24m	28m	14m	17m	−19m
Net income	81m	52m	51m	28m	16m	−32m
Earnings per share	0.51	0.33	0.33	0.18	0.10	−0.21
Earnings per share, diluted	0.50	0.32	0.31	0.17	0.10	−0.21
Weighted average shares	157m	157m	156m	155m	153m	149m
Weighted average shares, diluted	162m	165m	165m	166m	158m	149m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	248m	197m	356m	294m	288m	158m	50m	73m
Receivables	648m	628m	628m

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	236m	150m	—	—
Depreciation and amortisation	—	—	11m	9m
Share-based compensation	20m	12m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)